ReviewOncology research2026

Clinical Applications of CDK4/6 Inhibitors in HR+/HER2, and Personalized Treatment Strategies: A Narrative Review.

Guoliang Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.